Company Filing History:
1 out of 3 
1 out of 2 Years Active: 2000
Title: Biography of Jennifer Catherine Learmont
Introduction
Jennifer Catherine Learmont is an accomplished inventor based in Patongo, Australia. She is known for her significant contributions to the field of medical research, particularly in the study of human immunodeficiency virus type 1 (HIV-1). Her innovative work has led to the development of non-pathogenic strains of HIV-1, which hold promise for advancing diagnostic methods and understanding the virus's pathogenicity.
Latest Patents
Jennifer holds a patent for her invention titled "Non-pathogenic strains of HIV-1 containing mutations in the NEF gene." This invention focuses on non-pathogenic HIV-1 strains that exhibit deletions in the nef gene and U3 region of the long terminal repeat (LTR). The research highlights the importance of these genetic modifications in determining the pathogenicity of HIV-1.
Career Highlights
Throughout her career, Jennifer has worked with notable organizations, including the Macfarlane Burnet Centre for Medical Research Limited and the Australian Red Cross Society. Her research has contributed to a better understanding of long-term nonprogressors (LTNPs) who remain free of HIV-1-related diseases despite being infected with the virus.
Collaborations
Jennifer has collaborated with esteemed colleagues such as Nicholas John Deacon and Dale Alan McPhee. These partnerships have enriched her research and have been instrumental in advancing the understanding of HIV-1